Re: Richard T. Bryan, Wenyu Liu, Sarah J. Pirrie, et al. Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study. Eur Urol 2021;80:12-5

被引：0

作者：

Hu, Henglong ^{[1
]}

机构：

[1] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Urol, Wuhan, Peoples R China

来源：

EUROPEAN UROLOGY | 2021年 / 80卷 / 03期

关键词：

D O I：

10.1016/j.eururo.2021.06.018

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E85 / E85

页数：1

共 6 条

[1] Comparing an Imaging-guided Pathway with the Standard Pathway for Staging Muscle-invasive Bladder Cancer: Preliminary Data from the BladderPath Study
Bryan, Richard T.
Liu, Wenyu
Pirrie, Sarah J.
Amir, Rashid
Gallagher, Jean
Hughes, Ana, I
Jefferson, Kieran P.
Knight, Allen
Nanton, Veronica
Mintz, Harriet P.
Pope, Ann M.
Catto, James W. F.
Patel, Prashant
James, Nicholas D.
EUROPEAN UROLOGY, 2021, 80 (01) : 12 - 15
[2] Re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-643
Bai, Yunjin
Yang, Yubo
Tang, Yin
EUROPEAN UROLOGY, 2020, 77 (06) : E158 - E158
[3] Re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020;77:636-43. Eur Urol 2020;77:e158 Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer?
Vila-Reyes, Helena
DeCastro, G. Joel
McKiernan, James M.
EUROPEAN UROLOGY, 2021, 79 (01) : E35 - E36
[4] Reply to Yunjin Bai, Yubo Yang, Yin Tang's Letter to the Editor, re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01, Study. Eur Urol 2020;77:636-643
Bandini, Marco
Necchi, Andrea
EUROPEAN UROLOGY, 2020, 77 (06) : E159 - E160
[5] Re: Helena Vila-Reyes, G. Joel DeCastro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36
Panebianco, Valeria
Del Giudice, Francesco
Narumi, Yoshifumi
Simone, Giuseppe
De Berardinis, Ettore
Catto, Jamed W. F.
EUROPEAN UROLOGY, 2021, 79 (02) : E52 - E53
[6] Reply to Valeria Panebianco, Francesco Del Giudice, Yoshifumi Narumi, Giuseppe Simone, Ettore De Berardinis, and James Catto's Letter to the Editor re: Helena Vila-Reyes, G. Joel De Castro, and James M. McKiernan's Letter to the Editor re: Yunjin Bai, Yubo Yang, and Yin Tang's Letter to the Editor re: Andrea Necchi, Marco Bandini, Giuseppina Calareso, et al. Multiparametric Magnetic Resonance Imaging as a Noninvasive Assessment of Tumor Response to Neoadjuvant Pembrolizumab in Muscle-invasive Bladder Cancer: Preliminary Findings from the PURE-01 Study. Eur Urol 2020; 77:636-43. Eur Urol 2020;77:e158: Can mpMRI Replace Conventional Transurethral Resection of Bladder Cancer? Eur Urol 2021;79:e35-e36
Vila-Reyes, Helena
DeCastro, G. Joel
McKiernan, James M.
EUROPEAN UROLOGY, 2021, 79 (02) : E54 - E55

← 1 →